Archive: 2009

GMEC collaborator, Dr Rachel McKendry (University College London), and her colleagues recently received a £2 million Grand Challenge award from the Engineering and Physical Sciences Research Council (EPSRC), for the development of multi-marker nanosensors for HIV diagnosis. The award compliments Dr McKendry’s current GMEC collaboration to develop similar novel diagnostics for other infectious diseases.

Delegates and speakers from the UK, Europe and North America gathered at the Royal Society in London on Tuesday 17th November to attend the GMEC Genetics in Transplantation Workshop. The meeting – the first of its kind in the UK – was set up to address platform technologies and the complexity of statistical analysis between two genomes, donor and recipient, and provide an overview on progress to date in some of the larger studies.

Following the successful conference “Biomarkers in Brain Disease” held in Oxford, United Kingdom on January 26-28, 2009 and co-hosted by the NYAS and GMEC, the proceedings of the meeting are now published and available to purchase here

The event will give an exciting opportunity to hear news and research developments in the areas of genetics, biomarkers and gene expression studies that are relevant to organ transplantation.

GMEC has been a strong supporter of the open innovation Bioscience Campus on the GSK site at Stevenage, UK. We were delighted when Lord Mandelson (Secretary of State BIS) recently announced the agreement to go ahead with this development, supported by joint funding from GSK, the UK Government, The Wellcome Trust, Technology Strategy Board and the East of England Development Agency.

A business plan is under discussion to provide a Centre for Imaging and Biomarkers (CIB) of global significance, to advance the development of personalised medicine in drug development and in clinical practice.

GMEC actively participated in the recent Office of Life Sciences (OLS) initiative to inform UK Government policy in the area of biomedical sciences. The initiative led to the publication on July 14th 2009, of the OLS Blueprint which outlines plans to put innovation at the heart of Healthcare and stated: –

“The Government will support the formation of a UK Life Sciences Super Cluster to co-ordinate work across industry, Higher Education and the NHS, and to boost international recognition of UK life sciences.”
OLS Blueprint, July 2009

Opportunities for In Vivo Science

30 Jun '09Mercure Castle Hotel

GMEC Integrative Mammalian Physiology and Pharmacology Meeting

The meeting aim was to clarify the strategy for the GMEC programme, particularly in relation to the need for animal models that accurately predict the clinical efficacy of therapies. The group also discussed how to ensure efficient technology, procedure and data transfer across the institutions, together with the standardisation of student training methods. The group are currently now identifying the programme priorities.

Biomarkers in Brain Disease

30 Jan '09Said Business School

The development of reliable biomarkers for brain disorders would dramatically accelerate research on the etiology, pathophysiology, disease progression and therapeutic development of many diseases including Alzheimer’s, Parkinson’s and multiple sclerosis.